The Phase 2 retatrutide trial in obesity (Jastreboff et al., NEJM 2023) hit 24.2% at 48 weeks
The injection vehicle is carefully selected to ensure compatibility with both active ingredients while maintaining appropriate pH, osmolality, and other physical characteristics necessary for subcutaneous administration
Description How It Works This dual-peptide approach accelerates internal healing mechanisms by: Stimulating Angiogenesis: BPC-157 induces the rapid formation of new blood vessels to supply oxygen and nutrients to damaged tissues
insurance is not applicable
Key Benefits: Weekly injections with minimal side effects Reduced appetite and fewer cravings Better portion control and lasting satiety Safe, steady fat loss over time Backed by clinical research and provider support Dual-Action Support for Lasting Results Dual-Hormone Power for Advanced Weight Loss Our advanced weekly weight loss injection uses a dual-action approach to help regulate appetite, support metabolic health, and promote effective fat loss over time
Together, they create a potent synergy, leading to greater fat loss and muscle gain compared to using either strategy alone
